Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorSILVESTRE, Odilson M.-
dc.contributor.authorBACAL, Fernando-
dc.contributor.authorRAMOS, Danusa-
dc.contributor.authorBELLETI, Elisangela-
dc.contributor.authorANDRADE, Jose L.-
dc.contributor.authorPUGLIESE, Vincenzo-
dc.contributor.authorANDRAUS, Wellington-
dc.contributor.authorFURTADO, Meive-
dc.contributor.authorCARRILHO, Flair J.-
dc.contributor.authorD'ALBUQUERQUE, Luiz C.-
dc.contributor.authorFARIAS, Alberto Q.-
dc.identifier.citationHEPATOLOGY, v.56, suppl.1, p.944A-944A, 2012-
dc.description.abstractBackground: The impact of end-stage liver disease (ESLD) severity in cardiac remodeling of patients with cirrhosis is unknown. Our aim was to correlate the severity of ESLD with morphologic and functional heart changes. Methods: 184 patients underwent a protocol providing data on the severity of ESLD and undergoing echocardiography to assess the diameters of the left atrium and right ventricle; the systolic and diastolic diameters of the left ventricle, interventricular septum, and posterior wall of the left ventricle; systolic pulmonary artery pressure; ejection fraction; and diastolic function. Severity of ESLD was assessed by the Model for End-Stage Liver Disease (MELD) score. Results: Left-atrial diameter (r=0.323; IC 95% 0.190-0.455; p<0.001), left-ventricular diastolic diameter (r=0.177; IC 95% 0.033-0.320; p=0.01) and systolic pulmonary artery pressure (r=0.185; IC 95% 0.036-0.335; p=0.02) significantly correlated with MELD score. Patients with MELD ≥16 had significantly higher left-atrial diameter and systolic pulmonary artery pressure, compared with patients with MELD scores <16 points. Conclusions: Changes in cardiac structure and function, as assessed by echocardiography, correlate with the severity of ESLD in patients with cirrhosis.-
dc.titleImpact of the severity of end-stage liver disease in cardiac remodeling-
dc.rights.holderCopyright WILEY-BLACKWELL-
dc.description.conferencedateNOV 09-13, 2012-
dc.description.conferencelocalBoston - MA, EUA-
dc.description.conferencename63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)-
dc.subject.wosGastroenterology & Hepatology-
dc.type.categorymeeting abstract-
dc.type.versionpublishedVersion-, Elisangela:Univ Sao Paulo, Sch Med, Sao Paulo, Brazil-
hcfmusp.description.issuesuppl 1-
Appears in Collections:

Comunicações em Eventos - FM/MGT
Departamento de Gastroenterologia - FM/MGT

Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC

Comunicações em Eventos - HC/InCor
Instituto do Coração - HC/InCor

Comunicações em Eventos - HC/InRad
Instituto de Radiologia - HC/InRad

Comunicações em Eventos - LIM/07
LIM/07 - Laboratório de Gastroenterologia Clínica e Experimental

Comunicações em Eventos - LIM/11
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação

Comunicações em Eventos - LIM/37
LIM/37 - Laboratório de Transplante e Cirurgia de Fígado

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.